Cargando…

Polycystins and mechanotransduction in bone

Detalles Bibliográficos
Autores principales:	Gargalionis, Antonios N., Basdra, Efthimia K., Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739716/ https://www.ncbi.nlm.nih.gov/pubmed/29290931 http://dx.doi.org/10.18632/oncotarget.22421

Ejemplares similares

Polycystins and Mechanotransduction in Human Disease
por: Gargalionis, Antonios N., et al.
Publicado: (2019)

Polycystins, mechanotransduction and cancer development
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Polycystins in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2018)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

Mechanosignalling in tumour progression
por: Gargalionis, Antonios N., et al.
Publicado: (2017)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
por: Katsianou, Maria A., et al.
Publicado: (2022)

mTOR Signaling Components in Tumor Mechanobiology
por: Gargalionis, Antonios N., et al.
Publicado: (2022)

Solid Cancers and Rheumatoid Arthritis
por: Kalliolias, George D., et al.
Publicado: (2023)

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines
por: Papavassiliou, Kostas A., et al.
Publicado: (2019)

Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity
por: Varela, Aimilia, et al.
Publicado: (2015)

Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments
por: Pneumaticos, Spyros G, et al.
Publicado: (2010)

Targeting STAT3 Signaling Pathway in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2021)

Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis
por: Markouli, Mariam, et al.
Publicado: (2021)

Polycystin-2 Is Required for Chondrocyte Mechanotransduction and Traffics to the Primary Cilium in Response to Mechanical Stimulation
por: Thompson, Clare L., et al.
Publicado: (2021)

The ion channel function of polycystin‐1 in the polycystin‐1/polycystin‐2 complex
por: Wang, Zhifei, et al.
Publicado: (2019)

Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors
por: Manou, Maria, et al.
Publicado: (2023)

A polycystin-centric view of cyst formation and disease: the polycystins revisited
por: Ong, Albert CM, et al.
Publicado: (2015)

The molecular basis of bone mechanotransduction
por: Yavropoulou, M.P., et al.
Publicado: (2016)

Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway
por: Sigala, Fragiska, et al.
Publicado: (2010)

Talin: a protein designed for mechanotransduction
por: Burridge, Keith
Publicado: (2018)

A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes
por: Giamarchi, Aurélie, et al.
Publicado: (2010)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
por: Kassi, Eva N., et al.
Publicado: (2020)

Energetic landscape of polycystin channel gating
por: Ng, Leo CT, et al.
Publicado: (2023)

Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)

Polycystins and cellular Ca(2+) signaling
por: Mekahli, D., et al.
Publicado: (2012)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

A plasma membrane-localized polycystin-1/polycystin-2 complex in endothelial cells elicits vasodilation
por: MacKay, Charles E, et al.
Publicado: (2022)

Polycystin-1 Interacting Protein-1 (CU062) Interacts with the Ectodomain of Polycystin-1 (PC1)
por: Lea, Wendy A., et al.
Publicado: (2023)

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
por: Stravopodis, Dimitrios J., et al.
Publicado: (2023)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Polycystin-2 Associates With Malignancy in Meningiomas
por: Assimakopoulou, Martha, et al.
Publicado: (2023)

Polycystin-1 Surface Localization Is Stimulated by Polycystin-2 and Cleavage at the G Protein-coupled Receptor Proteolytic Site
por: Chapin, Hannah C., et al.
Publicado: (2010)

Editorial: Development, metabolism, senescence and mechanotransduction of bone
por: Patil, Suryaji, et al.
Publicado: (2022)

Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis
por: Katsianou, Maria A., et al.
Publicado: (2016)

Review series – Mechanotransduction from physiology to disease states
por: Cheng, Chao-Min, et al.
Publicado: (2013)

Identification of Polycystin-2 and CFTR common targets
por: Roxo-Rosa, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_duuqr0fedvgid2p6s3oafcl920